This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The Marchesini Group has signed a 48% acquisition of SEA Vision, provider of vision and inspection systems used in quality control and drug anti-counterfeiting. The operation consolidates years of business between the two companies, worth 125 million Euro with a long-term strategic agreement.
SEA Vision, based in the Lombardy region, employs over 100 people and plans to hire more, as it expects solid growth in 2018 due to drug serialization requirements in the EU, USA and China and now also in Brazil, Russia and North Africa.
SEA Vision will remain technically and commercially independent and will still be managed by its founders—Luigi Carrioli and Michele Cei— assisted by the Sales Director Marco Baietti and the CFO Matteo Boiardi, backed in the Board of Directors by Maurizio Marchesini (President of the Marchesini Group), Pietro Cassani (CEO) and Pietro Tomasi (Sales Director).
“We have been faced with Industry 4.0 for almost 20 years, well before it became a real trend,” said Pietro Cassani. “This agreement will allow us to create packaging machines that are even more unified with SEA Vision’s systems in order to guarantee customers a true 4.0 asset.”
